Leveraging the company’s deep therapeutic and la
Post# of 148184
(Total Views: 244)
Posted On: 07/11/2019 7:00:22 PM
Leveraging the company’s deep therapeutic and launch expertise, Syneos Health has helped to develop or commercialise 84% of Novel New Drugs approved by the FDA and 70% of products granted marketing and authorization by the European Medicine Agency (EMA) in a recent five year period.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼